Clinical Trial Update: FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FOLFOX-HAIC as conversion therapy to make initially unresectable colorectal liver metastases resectable. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Tongji Hospital | Conditions: Colorectal Liver Metastasis (CRLM) | Phase 2 | Status: RECRUITING